Forte Healthcare is an Irish animal healthcare company established in 2002. The business was founded in the veterinary pharmaceutical sector, initially distributing Cartrophen Vet, which has since become a widely recognised and respected product for the treatment of osteoarthritis in dogs.
Over more than two decades, Forte Healthcare has developed into an international animal healthcare business with a portfolio spanning veterinary pharmaceuticals and innovative, science-led non-medicinal solutions for companion, equine and production animals.
Our pharmaceutical heritage remains central to the business and has provided Forte Healthcare with a strong foundation in veterinary science, regulatory affairs, technical support and international product registration. This expertise increasingly informs the development of our non-medicinal portfolio, where our focus is firmly on non-medicinal products with efficacy.
Through ARKequine, Ark Animal Care and our companion animal portfolio, we are developing and commercialising products that address clearly identified animal health needs and are supported by strong technical and scientific rationale.
Immune health is a particular area of focus, alongside gastrointestinal health, recovery, mobility, skin and coat health, nutrition and performance. We are particularly interested in solutions that support the animal's own natural defences, promote resilience and help maintain health and performance at key periods of challenge.
As animal healthcare continues to evolve, we believe effective non-medicinal interventions have an increasingly important role to play alongside veterinary medicines. Our objective is to provide veterinarians, animal owners and producers with credible, evidence-led solutions that support preventative health strategies and, where appropriate, can contribute to reducing reliance on medicines while maintaining high standards of animal health and welfare.
Forte Healthcare now exports to more than 36 countries across Europe, Asia and the Middle East. Our international growth is supported by significant in-house expertise in regulatory affairs, technical support, sales and export market development.
We are now seeking to expand our international distribution network and establish relationships with experienced distributors who understand their local animal healthcare markets and can successfully develop our brands within them.
With the scientific and regulatory foundations of a veterinary pharmaceutical company combined with a growing portfolio of innovative non-medicinal products, Forte Healthcare offers international distribution partners something different: Irish animal healthcare innovation, backed by science, technical expertise and a clear focus on efficacy.
Why work with us
Forte Healthcare combines over two decades of experience in veterinary pharmaceuticals with a growing international portfolio of innovative, science-led non-medicinal animal healthcare products.
Our pharmaceutical heritage provides a strong foundation in scientific evaluation, regulatory affairs and technical support. These same standards are applied to our non-medicinal portfolio, where our focus is on non-medicinal solutions with demonstrated efficacy that address clearly defined animal health needs. We see particular value in products that support immune function, resilience and preventative health strategies and which, where appropriate, can contribute to the responsible use and reduction of medicines.
A key strength of Forte Healthcare is our ability to understand and respond to the requirements of individual markets. Animal health challenges vary considerably according to climate, husbandry practices, production systems, nutrition and disease pressures. We consider these factors carefully when evaluating opportunities and work with our distribution partners to ensure that products are relevant to the conditions and practices within their territories.
Our flexible product development model further supports this approach. Where a specific market requirement or commercial opportunity has been identified, we have the capability to adapt existing products or develop market-specific formulations. This enables us to address local requirements while maintaining appropriate standards of quality, technical rationale and commercial viability.
As an independent Irish company, Forte Healthcare also benefits from a relatively agile organisational structure. We can evaluate opportunities and make commercial and product-development decisions efficiently, allowing us to respond to changing market requirements and emerging opportunities more quickly than may be possible within larger organisations.
Our international partners are supported by established in-house expertise across regulatory affairs, technical services, commercial development and export management. This provides distributors with access to the knowledge and resources required to introduce, position and develop our products effectively within their markets.
Forte Healthcare currently exports to more than 36 countries across Europe, Asia and the Middle East. This international experience has given us a strong understanding of the regulatory, technical and commercial considerations involved in establishing animal healthcare products across diverse markets.
Our proposition to international distributors is therefore built on a clear combination of strengths: established veterinary pharmaceutical expertise, a strong and expanding non-medicinal portfolio, the ability to respond to market-specific requirements, and an agile approach to international business development.
We seek to build long-term distribution partnerships with companies that have strong knowledge of their local animal healthcare sectors and share our commitment to bringing effective, innovative and commercially relevant products to their markets.
